Lv41
438 积分 2023-08-01 加入
Systematic Evaluation of Maleimide Spacer Impact on Drug-Linker Deconjugation in Antibody-Drug Conjugates Ex Vivo and In Vivo
4天前
已完结
Beyond the Guided Missile Paradigm: Embracing the Complexity of Antibody-Drug Conjugates
4天前
已完结
An FDA oncology analysis of CD3 bispecific constructs and first-in-human dose selection
1个月前
已完结
POS0017 Bispecific T Cell-Engaging Antibodies to Target TRBV9+ Autoreactive T Cells in Axial Spondyloarthritis
1个月前
已关闭
POS0017 Bispecific T Cell-Engaging Antibodies to Target TRBV9+ Autoreactive T Cells in Axial Spondyloarthritis
1个月前
已关闭
T-cell-engaging bispecific antibodies in cancer
4个月前
已完结
Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study
6个月前
已完结
Optimization of Drug-Linker to Enable Long-term Storage of Antibody–Drug Conjugate for Subcutaneous Dosing
8个月前
已完结
Endometrial Cancer
8个月前
已完结
Endometrial cancer
8个月前
已完结
皖公网安备34019202002308
